A Naive Lung Adenocarcinoma Harboring G1269A ALK Resistance Mutation

• Olfa Trabelsi-Grati, MD,
• Elsy El-Alam, MD,
• Samia Melaabi, MD,
• Yves Allory, MD, PhD,
• Ivan Bièche, PharmD, PhD,
• Nicolas Girard, MD, PhD,
• Céline Callens, PharmD, PhD

Affiliations

Olfa Trabelsi-Grati, MD

Department of Genetics, Institut Curie Hospital, Paris, France; Corresponding author. Address for correspondence: Olfa Trabelsi-Grati, MD, Department of Genetics, Institut Curie Hospital, 26 rue d’Ulm, Paris 75005, France.

Elsy El-Alam, MD

Department of Pathology, Institut Curie Hospital, Saint-Cloud, France

Samia Melaabi, MD

Department of Genetics, Institut Curie Hospital, Paris, France

Yves Allory, MD, PhD

Department of Pathology, Institut Curie Hospital, Saint-Cloud, France

Ivan Bièche, PharmD, PhD

Department of Genetics, Institut Curie Hospital, Paris, France

Nicolas Girard, MD, PhD

Department of Oncology, Institut Curie Hospital, Paris, France

Céline Callens, PharmD, PhD

Department of Genetics, Institut Curie Hospital, Paris, France